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Abstract  
Many economic evaluations of health care changes rely on quality-adjusted life year (QALY) 
estimates. Notably, though, the QALY approach values health states rather than changes in 
health states. Hence a gain in health is only indirectly valued through ex ante preference 
elicitation on health states and subsequent subtraction of health state values from one another, 
rather than valued directly. There is therefore an underlying assumption of intra-person 
interval property i.e. that individuals from an ex ante perspective ceteris paribus would be 
indifferent between equal utility increments from health states with different baseline utilities.  
Using established preference elicitation methods, we set up an experiment on a sample of UK 
individuals. Based on the results, we can reject the notion of intra-person interval property, 
implying that the subtraction approach could lead to sub-optimal resource allocations. This 
suggests that a new approach for valuing health changes directly would better reflect 
individual preferences and this paper provides a viable methodology to achieve this.   
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1. Background 
In economic evaluation of health care interventions, the incremental cost of a programme is 
compared against the incremental health improvement. In particular, a cost-utility analysis 
involves a comparison of quality-adjusted life years (QALYs) gained with marginal cost 
changes where the QALY measure captures both quality and quantity gains (Drummond et 
al., 2005). Using the standard QALY procedure, the marginal change in health resulting from 
a health care intervention is indirectly approximated through ex ante preference elicitation on 
health states and subsequent subtraction of health state utility scores from one another (Nord 
et al., 2010). This subtraction method assumes that individuals from an ex ante perspective 
ceteris paribus would be indifferent between a marginal gain in utility from a health state 
associated with a high utility and an equally sized marginal gain in utility from a health state 
associated with a low utility. The implicit assumption is thereby the intra-person interval 
property as defined in Torrance (2006 p 1074); “a gain of equal utility increments anywhere 
on the scale should be equally preferable for the individual whose utilities are being 
represented. For example, if an individual’s utilities are A=0.2, B=0.4, C=0.6 and D=0.8, the 
person should be indifferent to whether the change is from A to B or from C to D”. 
According to Torrance (2006) and to the best knowledge of the authors, the intra-person 
interval property has, so far, not been tested. If it was found not to hold, any cost-utility 
analysis might need to account for different reference points (baseline utility) to relax the 
assumption of intra-person interval property.   
The aim of this paper is to test whether the intra-personal utility property holds in a sample of 
UK individuals. To do this, it is necessary to measure individual-based preferences over 
different health changes, as opposed to measuring the social preferences for changes (e.g. 
(Dolan et al. 2005; Gyrd-Hansen 2004; Lancsar et al. 2011; Exel et al., 2015). We elicit this 
data using face-to-face interviews. By asking individuals to make direct comparisons between 
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equal utility increments (from health states with different baseline utilities) we obtain 
rankings at the individual level, allowing a direct test of Torrance’s property. Although not 
central to this paper, we highlight a further potential advantage of our data, namely the 
measurement of the strength of such preferences. We leave to the end of the paper, a 
discussion as to how the findings in this paper may be translated into a health policy tool.  
 
The paper proceeds as follows. In Section 2, we describe the empirical study designed to test 
for the intra-person interval property and the analytical approach. Section 3 presents the 
results whereas the final section reflects on the implications for future research and policy 
formation. 
 
2. The Health Change Framework 
In the experiment, we follow Torrance (2006) and test whether individuals looking through a 
“veil of ignorance”, not knowing which outcomes and choices might occur to them in the 
future, would agree in advance that a change for them from 0.2 to 0.4 is equally preferable to 
a change from 0.6 to 0.8. Hence, we compare two changes at a time (X and Y) from two 
proposed levels of individual’s baseline utility of health (A and C). We use existing methods 
to represent the health states; the visual analogue scale (VAS), the HUI Mark 3 (HUI:3) 
(Horsman et al., 2003) and EQ-5D-5L and we use existing utility scores generated by the 
HUI:3 algorithm (Horsman
 
et al., 2003) and UK official crosswalk values for the EQ-5D-5 
(http://www.euroqol.org). The ranking of the two changes constitute Stage 1 of our analytical 
approach. By keeping gain X fixed and varying gain Y until the individual identifies their 
indifference point between the two utility increments from different proposed baselines we 
also illustrate (as a Stage 2) how strength of individual preferences can be elicited for 
different gains and baselines. 
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2.2. Experimental design  
A “common” experiment was designed varying only in terms of the method used to represent 
health states; the VAS, HUI:3 and EQ-5D-5L.  Due to the potential for fatigue, if subjects 
were asked to answer all variants, the experiment was applied on two separate samples: 
Sample I; students (from the Universities of York and Newcastle) and Sample II; members of 
the general public (Newcastle-upon-Tyne). Subjects in Sample I were randomised into either 
VASS
 
or HUIS, whereas subjects in Sample II were randomised into either VASP or EQ5DP.
 
 
 
TABLE 1 AROUND HERE 
 
2.3. Experimental procedures 
A total of 170 subjects participated in the experiment. All experimental sessions were face-to-
face interviews attended by only one participant and the interviewer. An example of 
experimental instructions is included in the Appendix. Prior to the experiment itself, a 
piloting phase was carried out in order to test for comprehension. Following the pilot, 
experimental instructions were further amended and more training exercises included.  This 
process allowed us to verify that the experimental instructions were understood by as many 
participants as possible, a crucial feature of any new method and, as much as is possible, to 
establish that subjects understood the concept of a health change. Core procedures, questions 
etc. were identical across the samples. However, a more extensive introduction and 
explanation was required for Sample II to ensure they understood the task. Thus, while the 
experiment generates treatment-specific results, we refrain from any direct comparisons due 
to this difference in information communication. Nevertheless, we are still able to draw broad 
qualitative conclusions from the two sets of responses.  
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Firstly, as a warm-up, participants were asked to read a small number of cards (usually two or 
three), and to show on a VAS where they felt each particular state would be placed.  The 
purpose of this was to observe whether the participant understood the descriptions on the 
cards, and that “better” states should be placed higher on the scale than “worse” states. In 
VASS, a HUI card was used whereas in VASP, an EQ5D card was used. Participants in 
sample II then undertook a short exercise in which they were asked to imagine themselves 
experiencing severe problems with each of the health dimensions. They were then asked to 
rank each of the 5 dimensions from “easiest to cope with” to “most difficult to cope with”. 
Following this, subjects in Sample II were asked to think about what different marginal 
improvements in these dimensions (e.g. from “moderate” problems to “slight” problems) 
might mean for them. The aim was to help them to focus on health changes. Participants were 
then given time to compare two health states, before choosing which of the two they would 
prefer. The two cards chosen for this exercise were selected so that one of the health states 
described on the cards dominated the other one (e.g. 21232 logically dominates 32442 
because it is better on the first four dimensions and no worse on the fifth).  The same exercise 
was then repeated with two different cards, but in this case the two cards were identical other 
than for mobility, for which one card had no problems, and the other had slight problems. 
Following these initial exercises, the concept of health gains was re-introduced by asking 
participants to imagine that they are given a treatment that would deliver either health gain X 
or health gain Y. EQ5D cards were chosen so that health gain X represented a small gain to 
very good health, whilst health gain Y represented a large gain from extremely poor health. 
After the warm up and training exercises, the actual preference elicitation exercise was 
carried out on both Sample I and II. This is described in the following section.  
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2.4. Eliciting Preferences over Changes in Health states  
In all variants, six questions were asked to each individual subject.  Individuals were shown 
two health changes, “X” and “Y”, each with different baseline states; therefore four health 
states were presented (a baseline and final health state for change “X” (health states A and B) 
and similarly for change “Y” (health states C and D)). Participants were asked to choose 
which of X and Y they thought offered the “best” change. These subject responses will be 
reported as Stage 1 results. Examples of the presentation of health improvement X are shown 
in the Appendix (for VASS+P, HUI and EQ5D)). It was explicitly stated that the subject should 
imagine herself in the health states described, as opposed to choosing on behalf of other 
individuals. Table 2 shows the health state changes offered under the three treatments in 
Stage 1. Each respondent was asked to compare X and Y, where X offers a gain from a good 
baseline utility state to a better utility state whilst Y offers a gain from a poorer baseline 
utility.  
 
TABLE 2 AROUND HERE 
 
Following this, different alternatives to health state D were presented to the respondent and 
hence the magnitude of gain Y was varied until the respondent indicated indifference 
between gain X and Y. The health gain Y chosen by the individual will be denoted Y* and 
will be reported as Stage 2 results as well as the associated health state D* identified by the 
individual. So, for example, in Q10.25 (VAS Treatment) respondents are shown a change X 
from a good baseline health state to an improved health state (A to B; 0.75 to 1.0) and are 
asked to identify the change Y* from a baseline health state C with a utility score of 0.5 to 
that health state D* which makes them indifferent between X and Y*.  To identify D*, a total 
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of 21 VAS cards were available to the participants (increments of 0.1). For HUIS and EQ5DP, 
18 combinations were chosen to represent health related quality of life utilities at equal 
intervals of around 0.06, ranging from 0 to 1. These utility levels are reported in Table A1-2 
in the Appendix and were generated by the HUI:3 algorithm and taken from the official UK 
values for the EQ5D.  For the purpose of our analyses, we will assume that the average utility 
score attributed to each health states will represent the utility score for the individual 
participant. Care was taken to ensure that, for each card representing one of the 18 health 
states, all levels were either equal or better than for the corresponding dimensions in the 
adjacent lower card.  If the participant did not explicitly state indifference between any two 
specific changes, it was assumed that the point of indifference was exactly halfway between 
the two changes where the preference changed from X to Y or Y to X.  The ordering of 
questions asked was randomised. Participants were encouraged to ask questions throughout 
the interview with respect to procedures and the interviewer was instructed to clarify any 
misunderstandings.  
 
TABLE 2 AROUND HERE 
 
 
2.5. Analytical approach: Testing for Intra-person interval property 
We report the experimental data in two stages. Stage 1 is based on the individual data for 
whether individuals were indifferent between gain X and gain Y or whether one was 
preferred to the other. The main research question we set out to test is RQ1;   
RQ 1; Do the data comply with the Intra-person interval property? 
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We test using unpaired two-sided t-tests, whether the proportion of subjects who stated that 
gain X and gain Y were equally preferred is significantly different from the proportion who 
indicated a preference for either X or Y.  If the Intra-person interval property is not fulfilled, 
i.e. subjects were not indifferent between the gains, we analyse individual preferences in 
more details in RQ1a +b. 
RQ1a; Do individuals on average prefer an “equal” increment in health from a poorer 
baseline utility state? 
We test using one-sided t-tests, whether the proportion of subjects who preferred gain Y (i.e. 
an equivalent gain from a poorer starting point) was significantly different from the 
proportion of subjects who did not prefer gain Y.  
RQ1b; Do individuals on average prefer an “equal” increment in health from a better 
baseline utility state? 
We test, using one-sided t-tests whether the proportion of subjects who preferred gain X (i.e. 
an equivalent gain from a better baseline) was significantly different from the proportion of 
subjects who did not prefer gain X.  
In addition we report and examine Stage 2 results i.e. individuals’ strength of preferences as 
elicited in the experiment. Hence, we report the average health state D* identified in the two 
samples and the associated gain Y*. 
3. Results  
Table 3-4 reports, the experimental Stage 1 data for the six questions. We first state the 
number of individuals who indicated strict preference for either Y, X or were indifferent. In 
both samples and across all health state measurement methods we reject the notion of intra-
person interval property as all p-values are <0.01. 
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TABLE 3 AROUND HERE 
TABLE 4 AROUND HERE 
 
Turning to RQ1a, we test whether subjects prefer a change from a poor baseline utility of 
health to an equally sized change from a good baseline utility of health state. The results from 
both VASS and HUIS are clear and we cannot reject that these respondents prefer a change 
from a poorer health state. The results from Sample II are more ambiguous. In VASP, when 
the utility gain X is 0.5 or above (Q4-Q6) we can draw the same conclusions. However, when 
the utility gain X is 0.25, we cannot reject based on a one-sided test that the subjects were 
indifferent between the changes. This pattern is not mirrored in EQ5DP where the only 
situation where subjects strictly preferred gain X was from the worst utility state given in Q6. 
In RQ1b, the one-sided alternative is that participants prefer a change from a good baseline 
utility to an equal change from a poor baseline utility state. The results from both VASS,, 
VASP and HUIS are clear: this change is not preferred.
 
However in the EQ5DP results we can 
identify that gain X is strictly preferred or the subjects are indifferent between the health 
changes for 5 of the 6 questions, only in Q6 is Gain X not preferred.  
Table 5 reports the Stage 2 results. For a Gain X of 0.25 (Q1-Q3), we see that this is 
perceived by individuals to be equivalent to a gain Y* ranging from 0.1 to 0.43 depending on 
sample, baseline and elicitation method.  A gain X of 0.5 is equivalent to a gain Y* ranging 
from 0.24-0.54 whereas a gain X of 0.75 is equivalent to a gain Y* in the range of 0.29 to 
0.55.  In general, we can see that that gain Y* is smaller than the corresponding gain X in 
almost all situations, but given the small sample sizes and different elicitation methods 
utilized, we will only draw broad qualitative conclusions and not apply statistical inference at 
this time.  
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TABLE 5 AROUND HERE 
Overall, based on this, we can reject that subjects in this data set comply with the intra-person 
interval property. Based on the results of RQ1a-b, we can infer that the main reason for this is 
explained by RQ1a i.e. that individuals prefer an “equal” increment from a poorer baseline 
utility state. However, in EQ5DP some subjects express preference for a gain when the 
baseline health state is associated with higher utility 
 
4. Discussion and conclusions 
In this paper we have tested whether the intra-person interval property holds in a sample of 
UK individuals. Based on the Stage 1 results, we can reject the notion of intra-person interval 
property in this data set. In Sample I, there was a clear tendency to prefer an equal utility 
increment from an initially more severe utility of health state compared to a better baseline 
state. Overall, the VAS results were similar in Sample II, although the tendency to prefer 
marginal changes from a more severe baseline was not significant when the utility score of 
the baseline health state in gain X was high. These results are overall similar to previous 
findings in other decision contexts where it has been found that people prefer to give priority 
to severely ill patients (Nord, 1995; Ubel et al., 1999). In contrast, for the EQ5D results there 
was a tendency to prefer equal utility increments from the good baseline utility to marginal 
changes from an initially more inferior baseline   Whilst these findings come with the caveat 
that they might be at least partially driven by any biases in the heath state measurement 
method itself it is unlikely that they are solely driven by this. One limitation of the current 
study is that average utility scores were assumed to represent the utility score for the 
individual participant.  Preceding the elicitation task described here with an individual 
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elicitation of utility scores, is a topic for further empirical investigation. Overall, we consider 
the evidence against the intra-person interval property in these two samples to be convincing. 
In fact, it is quite possible that certain sections of the spectrum (for example, very close to 
zero) not covered in this experiment may exhibit alternative outcomes. By varying one gain 
until the individual identifies indifference between two changes in individual’s utility of 
health from different proposed baselines, in Stage 2 we also illustrate how not only individual 
rankings but also strength of individual preferences can be elicited.  The methods described 
in this paper would allow the decision maker to value the individual’s change in health, 
which may be greater or less than that assumed under the more traditional methods. 
 
Taken as a whole, these findings call into question the use of the subtraction method for 
assigning values to any change in health states delivered by an intervention, particularly for 
the range of health states within the study. Whether this holds for the entire range of utility 
improvements that could be delivered and/or is generalizable to the wider population is an 
open question, one for further research. Likewise, a bigger data set would be needed to test 
whether strength of preferences are significantly different across different baseline and 
measurement methods. However, our study has laid the foundations for a method that could 
address this question, one which is more representative of underlying preferences than 
current practice. Furthermore, we have demonstrated this method to be empirically tractable 
in the field. The proposed method utilises utility scores elicited using standard methods such 
as Standard Gamble and Time-Trade-Off and it is a question for future research whether 
standard elicitation methods can be adapted instead to directly take into account the findings 
in this paper.  
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To finish, we offer a suggestion as to how this individual-based method could be used as a 
health policy tool, by way of what we would term a “Health Improvement Index” (HII). This 
HII would contain country-specific values for a range of different health state changes across 
the baseline spectrum. Whilst the initial construction of such an index would be an 
empirically daunting prospect it can be considered to be a one-off task as once the individual 
indifference points have been elicited, any proposed health improvement can be valued 
relatively easily. Based on the empirical results in this paper, we do believe that changing the 
focus of evaluation to changes instead of end-points could more accurately reflect the true 
benefits in cost-utility analyses. Hence, a HII would be useful in any economic evaluation 
made by bodies such as NICE particularly because use of the subtraction approach could lead 
to sub-optimal resource allocations.  
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Appendix 
Table A1. Utility levels for HUI. In italics; levels used as baseline health states. 
Card Vision Hearing Speech Ambulation Dexterity Emotion Cognition Pain HUI 
I 1 1 1 1 1 1 1 1 1 
II 1 2 1 1 1 1 1 1 0.93 
III 1 2 1 1 1 1 1 2 0.88 
IV 1 2 1 1 1 2 1 2 0.82 
V 1 2 1 1 2 2 1 2 0.76 
VI 1 2 1 1 2 2 3 2 0.7 
VII 1 2 2 1 2 2 3 2 0.64 
VIII 1 2 3 1 2 2 3 2 0.58 
IX 1 2 3 2 2 2 3 2 0.52 
X 1 3 3 2 2 2 3 2 0.46 
XI 1 3 3 3 2 2 3 2 0.4 
XII 1 3 3 3 3 2 3 2 0.34 
XIII 1 3 4 3 3 2 3 2 0.28 
XIV 1 3 4 3 3 2 3 3 0.24 
XV 1 4 4 3 3 2 3 3 0.18 
XVI 3 4 4 3 3 2 3 3 0.12 
XVII 3 4 4 3 3 3 3 3 0.06 
XVIII 3 4 4 3 3 3 3 4 0 
 
Table A2. Utility levels for EQ-5D. In italics; levels used as baseline health states. 
Card Mobility 
Self-
care 
Usual 
activities 
Pain/discomfort Anxiety/depression EQ-5D 
I 1 1 1 1 1 1 
II 2 1 1 1 1 0.88 
III 3 1 1 1 1 0.85 
IV 3 1 1 1 2 0.79 
V 3 1 1 1 3 0.78 
VI 3 2 1 1 3 0.69 
VII 3 2 2 1 3 0.66 
VIII 3 2 2 2 3 0.57 
IX 3 3 2 2 3 0.55 
X 3 3 3 2 3 0.54 
XI 3 3 3 3 3 0.52 
XII 3 3 3 4 3 0.30 
XIII 3 3 4 4 3 0.23 
XIV 3 4 4 4 3 0.18 
XV 3 4 5 4 3 0.06 
XVI 3 5 5 4 3 -0.03 
 
In Press: Value in Health (Accepted 12 December 2016) 
 
15 
 
TABLES  
 
 
Table 1. Experimental Design 
Sample 
 
 
VAS* 
 
Method 
HUI:3* 
 
 
EQ5D* 
 
 
I  
    
 
 
VASS 
n=35 
 
HUIS 
n=35 
 
 
II  
 
 
 
VASP 
n=51 
 
 
 
 
EQ5DP 
n=51 
 
* Subscript s denotes students and p denotes general public 
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Table 2. Comparisons used in VASP+S, HUI:3S  and EQ-5DP. Stage 1 
 
 VAS HUI:3 EQ-5D 
 Gain X Gain Y Gain  X Gain Y Gain X Gain Y 
States A B C D A B C D A B C D 
Q10.25 0.75 1.0 0.5 0.75 0.76 1.0 0.52 0.76 0.78 1.0 0.55 0.78 
Q20.25 0.75 1.0 0.25 0.50 0.76 1.0 0.28 0.52 0.78 1.0 0.23 0.55 
Q30.25 0.75 1.0 0 0.25 0.76 1.0 0 0.28 0.78 1.0 0 0.23 
Q40.50 0.5 1.0 0.25 0.75 0.52 1.0 0.28 0.76 0.55 1.0 0.23 0.78 
Q50.50 0.5 1.0 0 0.5 0.52 1.0 0 0.52 0.55 1.0 0 0.55 
Q60.75 0.25 1.0 0 0.75 0.28 1.0 0 0.76 0.23 1.0 0 0.78 
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Table 3.  VASS+P; Stage 1 Data and test results 
VASS   Sample I, n=35 
 
Prefer  
Gain Y 
Prefer  
Gain X 
Indifferent 
Two-sided 
 t-test 
Intra-person interval 
property 
One-sided 
t-test 
Prefer Y 
RQ1a 
One-sided t-
test 
Prefer  X 
RQ1b 
Q10.25 30 (86 %) 1 (3 %) 4 (1%) p<0.01 p<0.01 p>0.99 
Q20.25 34 (97 %) 0 (0 %) 1 (0.3%) p<0.01 p<0.01 p>0.99 
Q30.25 34 (97 %) 1 (3 %) 0 (0%) p<0.01 p<0.01 p>0.99 
Q40.50 34 (97 %) 0 (0 %) 1 (0.3%) p<0.01 p<0.01 p>0.99 
Q50.50 35 (100%) 0 (0 %) 0 (0%) p<0.01 p<0.01 p>0.99 
Q60.75 35 (100%) 0 (0%) 0 (0%) p<0.01 p<0.01 p>0.99 
VASP   Sample II, n=51 
 
 
 
 
 
 
 
 
 
 
 Prefer 
Gain  Y 
Prefer 
Gain X 
Indifferent  
Two-sided 
 t-test 
Intra-person 
interval property 
  One-sided 
t-test 
Prefer  Y 
RQ1a 
One-sided t-
test 
Prefer  X 
RQ1b 
Q10.25 25 (49%) 15 (29%) 11 (22%) p<0.01 p=0.15 p=0.85 
Q20.25 25 (49%) 17(33%) 9 (18%) p<0.01 p=0.42 p=0.58 
Q30.25 29 (57%) 14 (27%) 8 (16%) p<0.01 p=0.18 p=0.82 
Q40.50 33 (65%) 14 (27%) 4 (8%) p<0.01 p<0.01 p>0.99 
Q50.50 32 (63%) 8 (16%) 11 (22%) p<0.01 p<0.01 p>0.99 
Q60.75 39 (76%) 8 (16%) 4 (8%) p<0.01 p<0.01 p>0.99 
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Table 4. HUI:3S and EQ-5DP; Stage 1 Data and test results 
HUI:3S  Sample I, n=35 
 
Prefer 
Gain  Y 
Prefer 
Gain X 
Indifferent  
Two-sided 
 t-test 
Intra-person interval 
property 
 One-sided 
t-test 
Prefer  Y 
RQ1a 
One-sided t-test 
Prefer  X 
RQ1b 
Q10.25 22 (63 %) 8 (23 %) 5 (15 %) p<0.01 p=0.01 p=0.99 
Q20.25 22 (63 %) 11 (31 %) 2 (6%) p<0.01 p=0.06 p=0.94 
Q30.25 29 (83%) 6 (17 %) 0 (0%) p<0.01 p<0.01 p>0.99 
Q40.50 30 (86 %) 4 (11 %) 1 (3%) p<0.01 p<0.01 p>0.99 
Q50.50 29 (83 %) 6 (17 %) 0 (0%) p<0.01 p<0.01 p>0.99 
Q60.75 32 (91 %) 3 (9 %) 0 0(%) p<0.01 p<0.01 p>0.99 
EQ-5DP  Sample II, n=51 
 
Prefer 
Gain  Y 
Prefer 
Gain X 
Indifferent  
Two-sided 
 t-test 
Intra-person interval 
property 
 One-sided 
t-test 
Prefer  Y 
RQ1a 
One-sided t-
test 
Prefer  X 
RQ1b 
Q10.25 23 (45%) 26 (51%) 2 (4%) p<0.01 p=0.67 p=0.33 
Q20.25 7 (14%) 41 (80%) 3( 6%) p<0.01 p=0.99 p=0.01 
Q30.25 16 (31%) 33 (65%) 2 (4%) p<0.01 p=0.99 p=0.01 
Q40.50 26 (51%) 23 (45%) 2 (4%) p<0.01 p=0.67 p=0.33 
Q50.50 16 (31%) 33 (65%) 2 (4%) p<0.01 p=0.99 p=0.01 
Q60.75 38 (75%) 11 (22%) 2 (4%) p<0.01 p<0.01 p>0.99 
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Table 5. Stage 2 results. Strength of preference for each gain from each baseline  
  VASS 
 
VASP 
 
HUIS 
 
EQ5DP 
 
 
 
Gain X D* Gain Y*  D* Gain Y*  D* Gain Y* D* Gain Y*  
Q10.25 0.25 0.66 0.16 0.72 0.22 0.73 0.21 0.74 0.19 
Q20.25 0.25 0.37 0.12 0.49 0.24 0.51 0.23 0.63 0.35 
Q30.25 0.25 0.10 0.10 0.24 0.24 0.15 0.15 0.43 0.43 
Q40.50 0.50 0.53 0.28 0.61 0.36 0.64 0.36 0.72 0.42 
Q50.50 0.50 0.24 0.24 0.37 0.37 0.29 0.29 0.54 0.54 
Q60.75 0.75 0.42 0.42 0.53 0.53 0.43 0.43 0.55 0.55 
 
 
 
 
 
 
